Neuroprotective effects of vitamin D in an Alzheimer's disease rat model: Improvement of mitochondrial dysfunction via calcium/calmodulin‐dependent protein kinase kinase 2 activation of Sirtuin1 phosphorylation

Abstract

AbstractMitochondrial dysfunction is an early event in Alzheimer's disease (AD) pathogenesis. To assess the impact of vitamin D3 (Vit.D) on neurogenesis, we investigated its role in mitigating cognitive impairment and mitochondrial dysfunction through calcium/calmodulin‐dependent protein kinase kinase 2 (CAMKK2)‐mediated phosphorylation of Sirtuin1 (SIRT1) in an aluminum‐chloride‐D‐galactose (AlCl3‐D‐gal)‐induced AD rat model. Rats were distributed into four groups: control, AlCl3 + D‐gal (10 + 60 mg/kg, ip), Vit.D (500 IU/kg, po), and AlCl3 + D‐gal+Vit.D. Novel object recognition (NOR), Morris Water Maze, and passive avoidance (PA) tests were used to measure memory abilities. The hippocampal tissue was used to assess vitamin D3 receptor (VDR) and peroxisome‐proliferator‐activated‐receptor‐γ‐coactivator‐1α (PGC‐1α) expression by quantitative real‐time polymerase chain reaction (qRT‐PCR), CAMKK2, p‐SIRT1, phosphorylated‐AMP‐activated protein kinase (p‐AMPK), dynamin‐related‐protein‐1 (Drp1), and mitofusin‐1 (Mnf1) proteins by western blot and Ca2+ levels, endothelial nitic oxide synthase (eNOS), superoxide dismutase (SOD), amyloid beta (Aβ), and phospho tau (p‐Tau) via enzyme‐linked immunosorbent assay(ELISA) in addition to histological and ultrastructural examination of rat's brain tissue. Vit.D‐attenuated hippocampal injury reversed the cognitive decline and Aβ aggregation, and elevated p‐Tau levels in the AlCl3 + D‐gal‐induced AD rat model. In AlCl3 + D‐gal‐exposed rats, Vit.D induced VDR expression, normalized Ca2+ levels, elevated CAMKK2, p‐AMPK, p‐SIRT1, and PGC‐1α expression. Vit.D reduced Drp1, induced Mnf1, increased mitochondrial membrane potential, preserved mitochondrial structure, restored normal mitochondrial function, and retained normal eNOS level and SOD activity in AlCl3 + D‐gal rats. In conclusion, our findings proved that Vit.D may ameliorate cognitive deficits in AlCl3 + D‐gal‐induced AD by restoring normal mitochondrial function and reducing inflammatory and oxidative stress via CAMKK2‐AMPK/SIRT1 pathway upregulation.